Jun 13 |
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.
|
Jun 12 |
Lilly's Retevmo gains traditional approval in thyroid cancer
|
Jun 12 |
Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan
|
Jun 12 |
GLP-1 obesity drug coverage dropped by Blue Cross Michigan: report
|
Jun 12 |
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
|
Jun 12 |
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
|
Jun 12 |
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
|
Jun 12 |
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
|
Jun 11 |
Oil prices, National Amusement ends Skydance talks: Market Domination
|
Jun 11 |
Eli Lilly's new Alzheimer's treatment could 'lift' drug market
|